A Double Mutation in Glycoprotein gB Compensates for Ineffective gD-Dependent Initiation of Herpes Simplex Virus Type 1 Infection

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Virology

• Publication date

  2010-09-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.01633-10PMID 20861246PMCID PMC2976401
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Herpes Simplex Virus gD Forms Distinct Complexes with Fusion Executors gB and gH/gL in Part through the C-terminal Profusion Domain*

  2009cited by this paper
• Generation of Herpesvirus Entry Mediator (HVEM)-Restricted Herpes Simplex Virus Type 1 Mutant Viruses: Resistance of HVEM-Expressing Cells and Identification of Mutations That Rescue Nectin-1 Recognition

  2009cited by this paper
• Structure of a trimeric variant of the Epstein–Barr virus glycoprotein B

  2009cited by this paper
• Bimolecular Complementation of Paramyxovirus Fusion and Hemagglutinin-Neuraminidase Proteins Enhances Fusion: Implications for the Mechanism of Fusion Triggering

  2009cited by this paper
• Cross Talk among the Glycoproteins Involved in Herpes Simplex Virus Entry and Fusion: the Interaction between gB and gH/gL Does Not Necessarily Require gD

  2009cited by this paper
• Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells

  2009cited by this paper
• Herpes Simplex Virus Glycoprotein B Associates with Target Membranes via Its Fusion Loops

  2009cited by this paper
• Entry of Herpes Simplex Virus 1 and Other Alphaherpesviruses via the Paired Immunoglobulin-Like Type 2 Receptor α

  2009cited by this paper
• Construction of a Fully Retargeted Herpes Simplex Virus 1 Recombinant Capable of Entering Cells Solely via Human Epidermal Growth Factor Receptor 2

  2008cited by this paper
• A Heptad Repeat in Herpes Simplex Virus 1 gH, Located Downstream of the α-Helix with Attributes of a Fusion Peptide, Is Critical for Virus Entry and Fusion

  2007cited by this paper
• Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L, and B

  2007cited by this paper
• Bimolecular complementation reveals that glycoproteins gB and gH/gL of herpes simplex virus interact with each other during cell fusion

  2007cited by this paper
• Complexes between Herpes Simplex Virus Glycoproteins gD, gB, and gH Detected in Cells by Complementation of Split Enhanced Green Fluorescent Protein

  2007cited by this paper
• Mutational Evidence of Internal Fusion Loops in Herpes Simplex Virus Glycoprotein B

  2007cited by this paper
• Crystal Structure of Glycoprotein B from Herpes Simplex Virus 1

  2006cited by this paper
• Humanization of the Bispecific Epidermal Growth Factor Receptor × CD3 Diabody and Its Efficacy as a Potential Clinical Reagent

  2006cited by this paper
• Cytoplasmic Residues of Herpes Simplex Virus Glycoprotein gE Required for Secondary Envelopment and Binding of Tegument Proteins VP22 and UL11 to gE and gD

  2006cited by this paper
• Construction and properties of a herpes simplex virus 1 designed to enter cells solely via the IL-13alpha2 receptor.

  2006cited by this paper
• Inactivation of herpes simplex type 1 gene vector on immobilized metal affinity chromatography: Oxidative damage by hydroxyl free radicals and its prevention

  2006cited by this paper
• Soluble V Domain of Nectin-1/HveC Enables Entry of Herpes Simplex Virus Type 1 (HSV-1) into HSV-Resistant Cells by Binding to Viral Glycoprotein D

  2006cited by this paper
• The Ectodomain of Herpes Simplex Virus Glycoprotein H Contains a Membrane α-Helix with Attributes of an Internal Fusion Peptide, Positionally Conserved in the Herpesviridae Family

  2005cited by this paper
• Structure of unliganded HSV gD reveals a mechanism for receptor‐mediated activation of virus entry

  2005cited by this paper
• A Heptad Repeat in Herpes Simplex Virus 1 gH, Located Downstream of the α-Helix with Attributes of a Fusion Peptide, Is Critical for Virus Entry and Fusion

  2005cited by this paper
• Glycoprotein D Receptor-Dependent, Low-pH-Independent Endocytic Entry of Herpes Simplex Virus Type 1

  2005cited by this paper
• Potential Nectin-1 Binding Site on Herpes Simplex Virus Glycoprotein D

  2005cited by this paper
• The pro-fusion domain of herpes simplex virus glycoprotein D (gD) interacts with the gD N terminus and is displaced by soluble forms of viral receptors.

  2005cited by this paper
• Host Range and Emerging and Reemerging Pathogens

  2005cited by this paper
• Antibody-targeted cell fusion

  2004influential reference
• Cellular and Viral Requirements for Rapid Endocytic Entry of Herpes Simplex Virus

  2004cited by this paper
• Pleckstrin homology domains: not just for phosphoinositides.

  2004cited by this paper
• The Herpes Simplex Virus JMP Mutant Enters Receptor-Negative J Cells through a Novel Pathway Independent of the Known Receptors nectin1, HveA, and nectin2

  2004cited by this paper
• Roles for Endocytosis and Low pH in Herpes Simplex Virus Entry into HeLa and Chinese Hamster Ovary Cells

  2003cited by this paper
• Mutations in the N-Terminal Domains of Nectin-1 and Nectin-2 Reveal Differences in Requirements for Entry of Various Alphaherpesviruses and for Nectin-Nectin Interactions

  2002cited by this paper
• Effects of Herpes Simplex Virus on Structure and Function of Nectin-1/HveC

  2002cited by this paper
• Nectin4/PRR4, a New Afadin-associated Member of the Nectin Family That Trans-interacts with Nectin1/PRR1 through V Domain Interaction*

  2001cited by this paper
• Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry.

  2001cited by this paper
• Herpes simplex virus glycoprotein D bound to the human receptor HveA.

  2001cited by this paper
• Development of a syngenic murine B16 cell line-derived melanoma susceptible to destruction by neuroattenuated HSV-1.

  2001cited by this paper
• Pseudotyping of Glycoprotein D-Deficient Herpes Simplex Virus Type 1 with Vesicular Stomatitis Virus Glycoprotein G Enables Mutant Virus Attachment and Entry

  2000cited by this paper
• A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry.

  1999cited by this paper
• The Ectodomain of a Novel Member of the Immunoglobulin Subfamily Related to the Poliovirus Receptor Has the Attributes of a Bona Fide Receptor for Herpes Simplex Virus Types 1 and 2 in Human Cells

  1998cited by this paper
• Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor.

  1998influential reference
• A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus.

  1998cited by this paper
• Incorporation of the Green Fluorescent Protein into the Herpes Simplex Virus Type 1 Capsid

  1998influential reference
• Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family.

  1996cited by this paper
• A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH

  1992cited by this paper
• Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration

  1989cited by this paper
• Identification of mar mutations in herpes simplex virus type 1 glycoprotein B which alter antigenic structure and function in virus penetration

  1989cited by this paper
• A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells

  1988cited by this paper
• Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration

  1988cited by this paper
• Role of Glycoprotein B of Herpes Simplex Virus Type 1 in Viral Entry and Cell Fusion

  1988cited by this paper
• Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1: evidence that gH is essential for virion infectivity.

  1988cited by this paper
• Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface.

  1987cited by this paper
• Linker-insertion nonsense and restriction-site deletion mutations of the gB glycoprotein gene of herpes simplex virus type 1

  1987cited by this paper
• Animal cell mutants defective in glycosaminoglycan biosynthesis.

  1985cited by this paper
• Mutations affecting conformation or sequence of neutralizing epitopes identified by reactivity of viable plaques segregate from syn and ts domains of HSV-1(F) gB gene.

  1984cited by this paper
• Nucleotide sequence of a region of the herpes simplex virus type 1 gB glycoprotein gene: mutations affecting rate of virus entry and cell fusion.

  1984cited by this paper
• Nucleotide sequences of herpes simplex virus type 1 (HSV-1) affecting virus entry, cell fusion, and production of glycoprotein gb (VP7).

  1982cited by this paper

• An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma

  2025cites this paper
• Engineering HSV-1 for oncolytic therapy: From molecular entry mechanisms to retargeting strategies

  2025cites this paper
• Retargeted oncolytic viruses engineered to remodel the tumor microenvironment for glioblastoma immunotherapy

  2025cites this paper
• Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications

  2025influential citation
• Durable tissue-specific transgene expression in newborn mice following intraperitoneal delivery of non-cytotoxic HSV vectors

  2025cites this paper
• Seek and destroy: Development of novel viral therapy for EGFR-expressing tumors

  2024cites this paper
• Induction of necroptosis in multinucleated giant cells induced by conditionally replicating syncytial oHSV in co-cultures of cancer cells and non-cancerous cells

  2024cites this paper
• Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors

  2024cites this paper
• Novel mutations in UL24 and gH rescue efficient infection of an HSV vector retargeted to TrkA

  2023cites this paper
• Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: A proof of principle

  2022influential citation
• Immunomodulatory Arming Factors—The Current Paradigm for Oncolytic Vectors Relies on Immune Stimulating Molecules

  2021cites this paper
• Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus

  2021cites this paper
• Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment

  2021cites this paper
• Antibody Screening System Using a Herpes Simplex Virus (HSV)-Based Probe To Identify a Novel Target for Receptor-Retargeted Oncolytic HSVs

  2021cites this paper
• Entry of Alphaherpesviruses.

  2020cites this paper
• ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity

  2020cites this paper
• Generation of an Oncolytic Herpes Simplex Viral Vector Completely Retargeted to the GDNF Receptor GFRα1 for Specific Infection of Breast Cancer Cells

  2020influential citation
• Herpes Simplex Virus Oncolytic Immunovirotherapy: The Blossoming Branch of Multimodal Therapy

  2020cites this paper
• Oncolytic HSV Vectors and Anti-Tumor Immunity.

  2020cites this paper
• Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability

  2020cites this paper
• Identification of 22 Novel Motifs of the Cell Entry Fusion Glycoprotein B of Oncolytic Herpes Simplex Viruses: Sequence Analysis and Literature Review

  2020cites this paper
• Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing Antibodies

  2020cites this paper
• GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival

  2019cites this paper
• Inhibition of Herpes Simplex Viruses, Types 1 and 2, by Ginsenoside 20(S)-Rg3

  2019cites this paper
• Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins

  2018cites this paper
• Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression

  2018cites this paper
• HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses

  2018influential citation
• Herpes Simplex Virus Vectors for Gene Transfer to the Central Nervous System

  2018cites this paper
• Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes

  2017cites this paper
• Insertion of a ligand to HER2 in gB retargets HSV tropism and obviates the need for activation of the other entry glycoproteins

  2017cites this paper
• Engineered HSV vector achieves safe long-term transgene expression in the central nervous system

  2017cites this paper
• Dual Ligand Insertion in gB and gD of Oncolytic Herpes Simplex Viruses for Retargeting to a Producer Vero Cell Line and to Cancer Cells

  2017cites this paper
• Simultaneous Insertion of Two Ligands in gD for Cultivation of Oncolytic Herpes Simplex Viruses in Noncancer Cells and Retargeting to Cancer Receptors

  2017cites this paper
• Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread

  2016cites this paper
• Retargeting of herpes simplex virus (HSV) vectors.

  2016cites this paper
• Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus

  2016cites this paper
• POLYCISTRONIC HSV VECTORS FOR THE DIFFERENTIATION OF EMBRYONIC STEM CELLS TOWARD A CARDIAC LINEAGE

  2015cites this paper
• Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity

  2015cites this paper
• A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2

  2015cites this paper
• The Engineering of a Novel Ligand in gH Confers to HSV an Expanded Tropism Independent of gD Activation by Its Receptors

  2015cites this paper
• Contribution of N-linked glycans on HSV-2 gB to cell-cell fusion and viral entry.

  2015cites this paper
• Use of miRNA Response Sequences to Block Off-target Replication and Increase the Safety of an Unattenuated, Glioblastoma-targeted Oncolytic HSV.

  2015cites this paper
• B Virus (Macacine herpesvirus 1) Glycoprotein D Is Functional but Dispensable for Virus Entry into Macaque and Human Skin Cells

  2015cites this paper
• Cancer Therapy : Preclinical DoxorubicinSynergizeswith 34 . 5 ENVE toEnhanceAntitumor Ef fi cacy against Metastatic Ovarian Cancer

  2014cites this paper
• Doxorubicin Synergizes with 34.5ENVE to Enhance Antitumor Efficacy against Metastatic Ovarian Cancer

  2014cites this paper
• Entry Glycoproteins HSVKinetics of Cell-Cell Fusion Induced by Virus ( HSV ) Glycoprotein gB Alter the Reveals that Mutations to Herpes Simplex Dual Split Protein-Based Fusion Assay

  2013cites this paper
• Regulation of Herpes Simplex Virus gB-Induced Cell-Cell Fusion by Mutant Forms of gH/gL in the Absence of gD and Cellular Receptors

  2013cites this paper
• Dual Split Protein-Based Fusion Assay Reveals that Mutations to Herpes Simplex Virus (HSV) Glycoprotein gB Alter the Kinetics of Cell-Cell Fusion Induced by HSV Entry Glycoproteins

  2013cites this paper
• Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus.

  2013cites this paper
• Cell-to-Cell Spread in Herpes Simplex Virus 1 Entry and the Requirement for Known gD Receptors Novel Mutations in gB and gH Circumvent

  2013cites this paper
• Complete Genome Sequence of the First Chinese Virulent Infectious Laryngotracheitis Virus

  2013cites this paper
• Replication-competent herpes simplex virus retargeted to HER2 as therapy for high-grade glioma.

  2012cites this paper
• Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma.

  2012cites this paper
• Genetic engineering and preclinical evaluation of oncolytic herpes simplex viruses retargeted to cancer-specific receptors

  2012influential citation
• Expression of HSV-1 Receptors in EBV-Associated Lymphoproliferative Disease Determines Susceptibility to Oncolytic HSV

  2012cites this paper
• The Effect of the Tumor Microenvironment on Oncolytic Virus Therapy for Glioblastoma

  2012cites this paper
• DEVELOPMENT OF A NEW CLASS OF MICRORNA CONTROLLED OHSV VECTORS FOR TREATMENT OF GLIOBLASTOMA

  2012cites this paper
• Microenvironment and Immunology ExtracellularMatrixProteinCCN 1 LimitsOncolyticEf fi cacy in Glioma

  2012cites this paper
• Novel Mutations in gB and gH Circumvent the Requirement for Known gD Receptors in Herpes Simplex Virus 1 Entry and Cell-to-Cell Spread

  2012cites this paper